Pneumonic plague is the most dangerous form of plague, caused by the bacterium Yersinia pestis infecting the lungs. Without antibiotic treatment, it kills roughly 98% of people who contract it, typically within four to seven days. It is also the only form of plague that spreads directly from person to person through respiratory droplets, making it a serious public health concern even though cases are rare today.
How It Differs From Other Forms of Plague
Plague comes in three forms, all caused by the same bacterium. Bubonic plague, the most common, infects the lymph nodes and produces painful swellings called buboes. Septicemic plague involves a bloodstream infection. Pneumonic plague targets the lungs. It can develop in two ways: a person can inhale contaminated droplets coughed out by someone already sick (called primary pneumonic plague), or an existing case of bubonic or septicemic plague can spread to the lungs if left untreated (called secondary pneumonic plague).
The critical distinction is transmission. Bubonic plague requires a flea bite or contact with an infected animal. Pneumonic plague passes between people through the air, which is why it triggers urgent containment measures whenever a case appears.
What Happens Inside the Lungs
Once inhaled, Yersinia pestis is remarkably effective at disabling the body’s first line of defense. The bacterium carries a needle-like injection system that punctures immune cells and delivers proteins directly into them. These proteins prevent the immune cells from engulfing and destroying the bacteria, essentially paralyzing the lung’s resident defenders, particularly the immune cells that normally patrol the air sacs.
This creates a deceptive early phase. The bacteria multiply rapidly in the lungs while the immune system barely responds. Researchers describe this as a “preinflammatory” stage, where the infection grows quietly with little resistance. Then, abruptly, the body mounts an overwhelming inflammatory response. This sudden flood of immune activity damages lung tissue and is what ultimately proves fatal. The two-phase pattern, quiet replication followed by catastrophic inflammation, is a major reason pneumonic plague progresses so quickly.
Symptoms and Timeline
The incubation period after inhaling the bacteria can be as short as one day, making pneumonic plague one of the fastest-moving infectious diseases. Early symptoms include fever, headache, and weakness. These quickly give way to a rapidly developing pneumonia with shortness of breath, chest pain, and coughing that may produce bloody or watery mucus.
The speed of progression is the defining feature. A person can go from feeling feverish to life-threatening respiratory failure in two to three days. This narrow window is why early suspicion and immediate treatment matter so much. The medical literature consistently notes that patients who begin antibiotics more than 24 hours after symptoms start face dramatically worse odds.
How It Spreads Between People
Pneumonic plague spreads through large respiratory droplets expelled by coughing. This is not the same as airborne transmission in the way measles spreads. The droplets are heavy enough that they don’t float through ventilation systems or linger in the air for long. Experiments measuring how far the bacteria travel from a coughing patient found the maximum distance was about one meter, or roughly 3.3 feet. Other studies have placed the outer limit at 1.12 meters (3.7 feet).
This means transmission requires close, face-to-face contact. Public health guidelines define close contact as being within about two meters of a coughing patient, and people who have spent time that close to an untreated case are given preventive antibiotics for seven days. The fact that very close proximity is needed helps explain why pneumonic plague outbreaks, while deadly, tend to remain relatively contained compared to diseases that spread through true airborne routes.
Survival Rates With and Without Treatment
Untreated pneumonic plague has a pooled death rate of 98%, based on a meta-analysis published by the CDC’s journal Emerging Infectious Diseases covering cases from 1946 to 2017. With antibiotic treatment, the picture improves significantly. The same analysis found a 17% death rate among treated patients, better than the 50% figure that had been widely cited in older medical literature for decades.
That 17% figure still makes pneumonic plague extremely serious, but it underscores that prompt treatment saves the majority of patients. Treatment typically involves intravenous antibiotics started as soon as plague is suspected, even before lab results come back. The course lasts 10 to 14 days or until two days after the fever breaks.
Diagnosis and Containment
Doctors diagnose plague by collecting blood samples or, in the case of pneumonic plague, sputum samples for laboratory testing. Because time is so critical, antibiotics are started immediately based on clinical suspicion rather than waiting for confirmation.
Anyone with suspected or confirmed pneumonic plague is isolated under respiratory droplet precautions. Patients wear surgical masks during transport. After 48 hours of antibiotic therapy, and once clinical improvement begins, the isolation requirements ease because the patient is no longer considered contagious. If an outbreak produces too many patients for individual isolation, those with pneumonic plague can be grouped together while receiving treatment.
People who were in close contact with a case before the patient had been on antibiotics for 48 hours receive a seven-day course of preventive antibiotics, typically oral medications from the fluoroquinolone or tetracycline families.
Where Pneumonic Plague Still Occurs
Plague has not been eradicated. The three most endemic countries today are the Democratic Republic of the Congo, Madagascar, and Peru. Madagascar sees cases of plague nearly every year during its epidemic season, which runs from September through April. In 2017, Madagascar experienced a large outbreak that included a significant number of pneumonic plague cases, prompting an international public health response.
In the United States, a handful of plague cases occur each year, mostly bubonic, concentrated in rural areas of the Southwest where wild rodents carry the bacterium. Pneumonic plague cases in developed countries are extremely rare, but the disease remains on global watchlists because of its rapid lethality, person-to-person spread, and potential for misuse as a bioterrorism agent. There is currently no widely available vaccine.